Business Description
Statera BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8575611046
Share Class Description:
STAB: Ordinary SharesCompare
Compare
Traded in other countries / regions
STAB.USA7CB.Germany IPO Date
2021-07-28Description
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.6 | |||||
| 9-Day RSI | 52.68 | |||||
| 14-Day RSI | 48.25 | |||||
| 6-1 Month Momentum % | -83.33 | |||||
| 12-1 Month Momentum % | -66.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.36 | |||||
| EV-to-EBITDA | -0.37 | |||||
| Earnings Yield (Greenblatt) % | -277.78 | |||||
| FCF Yield % | -87107.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:STAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Statera BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.517 | ||
| Beta | 268.65 | ||
| Volatility % | 127.15 | ||
| 14-Day RSI | 48.25 | ||
| 14-Day ATR ($) | 0.000702 | ||
| 20-Day SMA ($) | 0.000165 | ||
| 12-1 Month Momentum % | -66.67 | ||
| 52-Week Range ($) | 0.0001 - 0.0261 | ||
| Shares Outstanding (Mil) | 71.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Statera BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Statera BioPharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Statera BioPharma Inc Frequently Asked Questions
What is Statera BioPharma Inc(STAB)'s stock price today?
The current price of STAB is $0.00. The 52 week high of STAB is $0.03 and 52 week low is $0.00.
When is next earnings date of Statera BioPharma Inc(STAB)?
The next earnings date of Statera BioPharma Inc(STAB) is 2024-11-29 Est..
Does Statera BioPharma Inc(STAB) pay dividends? If so, how much?
Statera BioPharma Inc(STAB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers